COMMUNIQUÉS West-GlobeNewswire

Radient Technologies Inc. Appoints Two New Members to its Board of Directors
17/04/2019
EDMONTON, Alberta, April 17, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce that it has appointed Ms. Jocelyne F. Lafrenière and [...]
Why Women, the Fastest Growing Consumers of Cannabis, are the Demographic to Watch -- CFN Media
17/04/2019
SEATTLE, April 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an [...]
ADMA Biologics Granted U.S. Patent for Treatment and Prevention of Pneumococcal Infections
17/04/2019
Fifth Patent Issued to the Company in the U.S. Provides Coverage for Expanding the Company’s Hyperimmune IVIG Portfolio Through 2037 RAMSEY, N.J. and BOCA RATON, Fla., April 17, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, [...]
Myriad Genetics Named to Forbes 2019 List of America's Best Midsize Employers and the Women Tech Council’s 2019 Shatter List
17/04/2019
Creating a Culture of Diversity, Inclusion and Opportunity Is a Top Company Priority SALT LAKE CITY, April 17, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, [...]
iTeos Therapeutics Initiates Phase 1/1b Trial with Differentiated Adenosine A2A Antagonist in Patients with Advanced Cancer
17/04/2019
iTeos Therapeutics Initiates Phase 1/1b Trial with Differentiated Adenosine A 2A Antagonist in Patients with Advanced Cancer First cohort of patients with advanced cancer now dosed with EOS100850 Target enrollment of 72 [...]
Revive Therapeutics Announces United States Patent Grant for Cannabinoid Delivery System
17/04/2019
TORONTO, April 17, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development and [...]
OraSure Technologies Earnings Conference Call Invitation
17/04/2019
2019 First Quarter Earnings Conference Call Wednesday, May 8, 2019, 5:00 p.m. ET BETHLEHEM, Pa., April 17, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference [...]
Precision BioSciences Announces Dosing of First Patient in Off-The-Shelf CAR T Cell Therapy Phase 1/2a Clinical Trial
17/04/2019
First NHL patient treated with allogeneic CAR T in U.S.-based trial DURHAM, N.C., April 17, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving [...]
Correction: Announcement no. 3/2019 - Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse
17/04/2019
Announcement no. 3/2019 17 April 2019 Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse Coloplast was informed yesterday by the FDA that the PMA for [...]
Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse
17/04/2019
Coloplast was informed yesterday by the FDA that the PMA for Restorelle DirectFix Anterior is not approved and the company must cease marketing and distribution immediately. As a result, FDA regulations require that all [...]
Zealand Pharma announces amendments to its Articles of Association following the granting of warrants
17/04/2019
Company announcement – No. 14 / 2019 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, April 17, 2019 – Zealand Pharma (“Zealand”) announces that its [...]
Announcement no. 3/2019 - Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse
17/04/2019
Announcement no. 3/2019 17 April 2019 Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse Coloplast was informed yesterday by the FDA that the PMA for [...]
Acetium® lozenge for smoking intervention will shortly be distributed in Italy within Difar Consumer Care® product division
17/04/2019
Press release April 17th, 2019 at 09.30 local time (EEST) Biohit Oyj and Difar Distribuzione s.r.l have signed an agreement for the distribution of the Acetium® lozenge in Italy. CEO Semi Korpela, Biohit Oyj: “We are [...]
QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be evaluated by GlaxoSmithKline’s C&GT platform group.
17/04/2019
Press Release: 17 April 2019 QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be [...]
iTeos Therapeutics Initiates Phase 1/1b Trial with Differentiated Adenosine A2A Antagonist in Patients with Advanced Cancer
17/04/2019
iTeos Therapeutics Initiates Phase 1/1b Trial with Differentiated Adenosine A 2A Antagonist in Patients with Advanced Cancer First cohort of patients with advanced cancer now dosed with EOS100850 Target enrollment of 72 [...]
RESULTATS ANNUELS 2018
17/04/2019
RESULTATS ANNUELS 2018 Objectifs de rentabilité atteints avec un EBITDA à 5 M€ Poursuite du développement en biologie moléculaire (+36% à 9 M€) Structure financière solide pour des objectifs de croissance ambitieux [...]
AroCell establish a Scientific Advisory Board
17/04/2019
AroCell announces today that we have established a Scientific Advisory Board to support the company in its planned expansion for the coming years. The Scientific Advisory Board (SAB) will have the objective to support [...]
Notice of Annual General Meeting of Arocell ab (publ)
17/04/2019
Available in Swedish only Aktieägarna i AroCell AB (publ), org.nr 556596–6107 (”Bolaget”) kallas härmed till årsstämma torsdagen den 16 maj 2019, kl. 13 i lokalen Karin Boye på Virdings allé 32 B i Uppsala. [...]
Brainsway Ltd. Announces Pricing of Initial Public Offering of 2.5 Million American Depositary Shares
17/04/2019
JERUSALEM, Israel, April 16, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ: BWAY and TASE: BRIN) (“Brainsway”) today announced that it has priced its initial public offering of 2,500,000 American Depositary Shares (“ [...]

Pages